Epigenetix

Biotechnology ResearchFlorida, United States2-10 Employees

Epigenetix is a biotechnology research company based in Delray Beach, Florida, United States, with a small team estimated at 2–10 employees. It is a clinical-stage pharmaceutical company developing an oral cancer drug that is poised to enter phase trials at five leading US cancer centers. The drug targets three validated cancer targets—p300/CBP, BRD4, and CECR2—and has shown results including the elimination of tumors and associated metastases. While currently pursued as monotherapy, preclinical work indicates potential synergy with other therapies such as checkpoint inhibitors, PARP inhibitors, CDK4/6 inhibitors, and EZH2 inhibitors. More information is available on the company's website at https://epigenetix.com.

Sign up for free to view info

Email Format Employee directory